在接受米替福新治疗的内脏利什曼病后出现的黑热病后皮肤利什曼病。
Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis.
作者信息
Koley Sankha, Mandal Rajesh Kumar, Choudhary Sanjiv, Bandyopadhyay Arghya
机构信息
Department of Dermatology, North Bengal Medical College, West Bengal, India.
出版信息
Indian J Dermatol. 2013 May;58(3):241. doi: 10.4103/0019-5154.110848.
Abstract
Post-kala-azar dermal leishmaniasis (PKDL) is an unusual dermatosis occurring following an attack of visceral leishmaniasis (VL). There are only few reports of PKDL after successful treatment with miltefosine. We report two cases of PKDL that developed after successful treatment of VL with miltefosine.
摘要
黑热病后皮肤利什曼病（PKDL）是一种在内脏利什曼病（VL）发作后出现的罕见皮肤病。关于用米替福新成功治疗后发生PKDL的报告仅有几例。我们报告了两例在用米替福新成功治疗VL后发生的PKDL病例。
Zotero 插件